
Eps 264| How We Handle Drawdowns in Dividend Growth Investing
About this episode
In this episode, we dive into the realities of dealing with portfolio drawdowns as dividend growth investors. From personal examples to strategies for averaging down, price anchoring, and knowing when to hold or sell, we share how we manage the emotions that come with falling share prices.
We also cover the latest news and dividend hikes, including:
Novo Nordisk – promising results from its new oral weight-loss drug
London Stock Exchange Group – stepping into blockchain with Microsoft
Intel & Nvidia – surprising partnerships in the chip industry
Texas Instruments, Microsoft, W.P. Carey, and Philip Morris – dividend hike updates
Plus, we review Bradley’s dividend portfolio and answer listener questions on hedging against USD, quick dividend stock screeners, reinvestment strategies, tax-efficient accounts, and more.
🎙️ Tickers discussed: NVO, LSEG, INTC, NVDA, TXN, MSFT, WPC, PM, CNQ, LGEN, EOG, O, ARES, HASI, PLD, BAM, DTE, AD, VICI, PAYX, UNH, NEE, LVMH, UL
Get every episode summarized
Each time Dividend Talk publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Dividend Talk

Ep. 305: Should Cyclical Stocks Be in Your Dividend Portfolio? (BHP, Exxon, Rio...
Dividend Talk

Quick Update
Dividend Talk

Q2 2026 Earnings Season: IBM Crashes, TotalEnergies Shines | EP 304
Dividend Talk

EP 303: Dividend Investing with Belle Dividends | How to deal with a major cash...
Dividend Talk